Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10436101rdf:typepubmed:Citationlld:pubmed
pubmed-article:10436101lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0038454lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0021017lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0162596lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0474643lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0542560lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:10436101lifeskim:mentionsumls-concept:C0332291lld:lifeskim
pubmed-article:10436101pubmed:issue8lld:pubmed
pubmed-article:10436101pubmed:dateCreated1999-8-30lld:pubmed
pubmed-article:10436101pubmed:abstractTextPrevious studies have produced conflicting results regarding the putative association between anticardiolipin antibodies (aCL) and infarction in the general stroke population. These inconsistencies may be a function of sample size and methodological differences among the studies. The purpose of the present study, the largest case-control study of this issue to date, was to assess aCL status as an independent risk factor for ischemic stroke in a multiethnic, urban population.lld:pubmed
pubmed-article:10436101pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10436101pubmed:languageenglld:pubmed
pubmed-article:10436101pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10436101pubmed:citationSubsetIMlld:pubmed
pubmed-article:10436101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10436101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10436101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10436101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10436101pubmed:statusMEDLINElld:pubmed
pubmed-article:10436101pubmed:monthAuglld:pubmed
pubmed-article:10436101pubmed:issn0039-2499lld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:WeinbergerJJlld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:SenRRlld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:GoldmanM EMElld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:GodboldJ HJHlld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:TuhrimSSlld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:RandJ HJHlld:pubmed
pubmed-article:10436101pubmed:authorpubmed-author:HorowitzD RDRlld:pubmed
pubmed-article:10436101pubmed:issnTypePrintlld:pubmed
pubmed-article:10436101pubmed:volume30lld:pubmed
pubmed-article:10436101pubmed:ownerNLMlld:pubmed
pubmed-article:10436101pubmed:authorsCompleteYlld:pubmed
pubmed-article:10436101pubmed:pagination1561-5lld:pubmed
pubmed-article:10436101pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:meshHeadingpubmed-meshheading:10436101...lld:pubmed
pubmed-article:10436101pubmed:year1999lld:pubmed
pubmed-article:10436101pubmed:articleTitleElevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.lld:pubmed
pubmed-article:10436101pubmed:affiliationDepartment of Neurology, Mount Sinai School of Medicine, New York, NY, USA. s_turhim@mssm.edulld:pubmed
pubmed-article:10436101pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10436101pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10436101pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10436101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10436101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10436101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10436101lld:pubmed